Anzeige
Mehr »
Login
Mittwoch, 15.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Uran-Rallye: Preise ziehen wieder an - Jetzt nicht den Einstieg verpassen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
499 Leser
Artikel bewerten:
(2)

Boston Scientific Wins Two Edison Awards

NORTHAMPTON, MA / ACCESSWIRE / May 1, 2023 / Boston Scientific

Boston Scientific, Monday, May 1, 2023, Press release picture

The winners of this year's awards

Each day, Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of people around the world. Boston Scientific was recently recognized by the Edison Awards for two innovative products that are making a meaningful difference for the patients the company helps to serve.

EXALT Model B Single-Use Bronchoscope received a Gold award in the Medtech category. EXALT Model B has contributed to the evolution of the standard of care within bronchoscopy. The single-use bronchoscope was specifically designed and optimized for bedside procedures and features suction capabilities and the familiar feel of reusable models.

"At Boston Scientific, we are always pushing ourselves to drive innovation based on direct input from physicians," said Mike Jones, senior vice president and president, Endoscopy. "EXALT Model B was designed to help provide ease of navigation and visualization during bronchoscopies. It also helps improve operational efficiencies for hospitals by removing any unplanned downtime due to equipment out for repair or having to wait for the scopes to be cleaned."

Image guided programming with STIMVIEW XT technology was awarded a Silver award in Artificial Intelligence Assisted Medicine category. The advanced software, which is powered by our collaboration with Brainlab AG, is used with the Vercise Genus Deep Brain Stimulation (DBS) system that is designed to offer a streamlined approach to DBS programming for people living with Parkinson's disease. STIMVIEW XT uses patient-specific, 3D visualization of the anatomy and imaging of the implanted DBS lead to enable clinicians to see, shape and steer DBS therapy to where it's needed most.

"This recognition reinforces our ongoing commitment to deliver best-in-class innovations that ultimately help those living with Parkinson's," said Milad Girgis, vice president, general manager, Brain Franchise for Neuromodulation. "The technology behind STIMVIEW XT allows clinicians to personalize therapy and better address the unique needs of their patients."

The Edison Awards is an annual event honoring excellence in new product and service development, marketing, human-centered design and innovation. The awards symbolize the persistence and excellence personified by Thomas Edison and his Menlo Park team who successfully brought an unprecedented number of innovations to the market.

Learn about previous Edison Awards and more honors Boston Scientific has received for its innovation and leadership.

View original content here.

View additional multimedia and more ESG storytelling from Boston Scientific on 3blmedia.com.

Contact Info:
Spokesperson: Boston Scientific
Website: https://www.3blmedia.com/profiles/boston-scientific
Email: info@3blmedia.com

SOURCE: Boston Scientific

View source version on accesswire.com:
https://www.accesswire.com/752116/Boston-Scientific-Wins-Two-Edison-Awards

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2023 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.